Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study

por Anžič, Nina, Krasniqi, Fatime, Eberhardt, Anna-Lena, Tzankov, Alexandar, Haslbauer, Jasmin Dionne
Publicado 2021